by 
Ribonucleic acid or RNA plays a crucial role in various cellular processes and acts as a messenger between DNA and protein synthesis. RNA markers help in detecting alterations in RNA expressions and transcriptome analysis. These markers play an important role in gene expression profiling, developmental biology research, and disease pathology. Advancements in RNA sequencing technologies have enabled identification of alterations in transcriptomes for various diseases conditions like cancers. RNA markers help identify novel targets and design therapeutic interventions. Significant investments by pharmaceutical and biotechnology companies in RNA biomarker discovery and development of RNA sequencing technologies are expected to drive the demand for RNA markers over the forecast period.
The global Ribonucleic Acid (RNA) Markers Market is estimated to be valued at US$ 347.6 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Adoption of single cell RNA sequencing techniques is gaining traction rapidly. Single cell RNA sequencing helps understand transcriptome variations at a single cell resolution and provides insights into cellular heterogeneity. It helps in identifying rare subpopulations of cells and biomarkers that can potentially serve as therapeutic targets. Rising popularity of single cell RNA techniques among researchers is anticipated to boost the demand for RNA markers specifically designed for single cell applications. Growing investments by government and private players to further improve technologies and expand single cell analysis applications are likely to create new opportunities for key players in the RNA markers market over the forecast period.
Porter’s Analysis
Threat of new entrants: Low due to high manufacturing and regulatory costs. Bargaining power of buyers: High due to availability of substitutes. Bargaining power of suppliers: Moderate due to presence of a large number of raw material suppliers. Threat of new substitutes: Moderate as alternative diagnostic techniques pose limited threat. Competitive rivalry: High as key players continue introducing innovative products to gain market share.
Key Takeaways
The global Ribonucleic Acid (RNA) Markers Market is expected to witness high growth. North America dominated the market in 2022 due to high cancer burden and favorable reimbursement scenario. The Asia Pacific region is projected to witness the fastest CAGR during the forecast period due to growing public awareness, developing healthcare infrastructure, and rising healthcare expenditure.
Key players operating in the Ribonucleic Acid (RNA) Markers Market are Carl Zeiss AG, Hoya Corporation, Canon Inc., Nidek Co., Ltd., Topcon Corporation, Intelligent Retinal Imaging Systems, Inc., Kowa Company Ltd., Optomed Oy (Ltd.), Vision Equipment Inc., Clarity Medical Systems, Inc., Medimaging Integrated Solution Inc., S4OPTIK LLC., Shenzhen Thondar Technology Co., Ltd., CenterVue SpA. Regional analysis related content comprises
Key players are focusing on new product launches and strategic acquisitions to strengthen their market presence. For instance, in 2022, Carl Zeiss AG launched CIRRUS 6000, the latest in the CIRRUS family of spectral-domain optical coherence tomography systems. The system delivers advanced imaging capabilities and a fast, intuitive user experience.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
